Fingolimod attenuates ceramide-induced blood–brain barrier dysfunction in multiple sclerosis by targeting reactive astrocytes

R van Doorn, PG Nijland, N Dekker, ME Witte… - Acta …, 2012 - Springer
Alterations in sphingolipid metabolism are described to contribute to various neurological
disorders. We here determined the expression of enzymes involved in the sphingomyelin …
被引用次数：122 相关文章

Fingolimod attenuates ceramide-induced blood-brain barrier dysfunction in multiple sclerosis by targeting reactive astrocytes

R van Doorn, PG Nijland, N Dekker, ME Witte… - Acta …, 2012 - go.gale.com
Alterations in sphingolipid metabolism are described to contribute to various neurological
disorders. We here determined the expression of enzymes involved in the sphingomyelin …

Fingolimod attenuates ceramide-induced blood-brain barrier dysfunction in multiple sclerosis by targeting reactive astrocytes.

R Doorn, P Nijland, N Dekker, M Witte… - Acta …, 2012 - search.ebscohost.com
Alterations in sphingolipid metabolism are described to contribute to various neurological
disorders. We here determined the expression of enzymes involved in the sphingomyelin …

[引用][C] Fingolimod attenuates ceramide-induced blood–brain barrier dysfunction in multiple sclerosis by targeting reactive astrocytes

R van Doorn, PG Nijland, N Dekker, ME Witte… - Acta …, 2012 - cir.nii.ac.jp
Fingolimod attenuates ceramide-induced blood–brain barrier dysfunction in multiple
sclerosis by targeting reactive astrocytes | CiNii Research CiNii 国立情報学研究所 学術情報 …

Fingolimod attenuates ceramide-induced blood–brain barrier dysfunction in multiple sclerosis by targeting reactive astrocytes

R Doorn, PG Nijland, N Dekker, ME Witte… - Acta …, 2012 - infona.pl
Alterations in sphingolipid metabolism are described to contribute to various neurological
disorders. We here determined the expression of enzymes involved in the sphingomyelin …

Fingolimod attenuates ceramide-induced blood-brain barrier dysfunction in multiple sclerosis by targeting reactive astrocytes

RP van Doorn, PG Nijland… - Acta …, 2012 - researchinformation.amsterdamumc …
Alterations in sphingolipid metabolism are described to contribute to various neurological
disorders. We here determined the expression of enzymes involved in the sphingomyelin …

Fingolimod attenuates ceramide-induced blood-brain barrier dysfunction in multiple sclerosis by targeting reactive astrocytes.

R van Doorn, PG Nijland, N Dekker, ME Witte… - Acta …, 2012 - europepmc.org
Alterations in sphingolipid metabolism are described to contribute to various neurological
disorders. We here determined the expression of enzymes involved in the sphingomyelin …

Fingolimod attenuates ceramide-induced blood-brain barrier dysfunction in multiple sclerosis by targeting reactive astrocytes

R van Doorn, PG Nijland, N Dekker… - Acta …, 2012 - pubmed.ncbi.nlm.nih.gov
Alterations in sphingolipid metabolism are described to contribute to various neurological
disorders. We here determined the expression of enzymes involved in the sphingomyelin …
[PDF] academia.edu

[PDF][PDF] Fingolimod attenuates ceramide-induced blood–brain barrier dysfunction in multiple sclerosis by targeting reactive astrocytes

R van Doorn, PG Nijland, N Dekker, ME Witte… - Acta …, 2012 - academia.edu
Alterations in sphingolipid metabolism are described to contribute to various neurological
disorders. We here determined the expression of enzymes involved in the sphingomyelin …

Fingolimod attenuates ceramide-induced blood-brain barrier dysfunction in multiple sclerosis by targeting reactive astrocytes

R van Doorn, PG Nijland, N Dekker… - Acta …, 2012 - search.proquest.com
Alterations in sphingolipid metabolism are described to contribute to various neurological
disorders. We here determined the expression of enzymes involved in the sphingomyelin …